⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1650927 | 1.00 | — | — | |
| SCHEMBL29771483 | 1.00 | — | — | |
| SCHEMBL4595145 | 1.00 | — | — | |
| SCHEMBL15913 | 1.00 | — | — | |
| SCHEMBL8949676 | 1.00 | — | — | |
| SCHEMBL5141623 | 0.71 | — | — | |
| SCHEMBL1917094 | 0.71 | — | — | |
| Selenium SCHEMBL420182 | 0.71 | — | — | |
| SCHEMBL11347325 | 0.71 | — | — | |
| SCHEMBL1188017 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213737-A1 | MICROSPHERE AND PREPARATION METHOD THEREOF | PLATINUM OPTICS TECHNOLOGY INC. (TW) | 2025-07-03 | — | — | US | claimed |
| EP-4578496-A1 | MICROSPHERE AND PREPARATION METHOD THEREOF | Platinum Optics Technology Inc. (TW) | 2025-07-02 | — | — | EP | claimed |
| CN-118116504-B | Method for predicting adsorption behavior of arsenic on 2:1 clay mineral | 江西省科学院微生物研究所(江西省流域生态研究所) | 2024-08-27 | — | — | CN | claimed |
| CN-118116504-A | Method for predicting adsorption behavior of arsenic on 2:1 clay mineral | 江西省科学院微生物研究所(江西省流域生态研究所) | 2024-05-31 | — | — | CN | claimed |
| US-20230190810-A1 | ANTI-CD33 ANTIBODIES AND USES THEREOF | FRED HUTCHINSON CANCER CENTER (US) | 2023-06-22 | — | — | US | claimed |
| US-20230144405-A1 | HUMAN ANTI-CD33 ANTIBODIES AND USES THEREOF | FRED HUTCHINSON CANCER CENTER (US) | 2023-05-11 | — | — | US | claimed |
| EP-4126245-A2 | ANTI-CD33 ANTIBODIES AND USES THEREOF | Fred Hutchinson Cancer Center (US) | 2023-02-08 | — | — | EP | claimed |
| EP-4126248-A2 | HUMAN ANTI-CD33 ANTIBODIES AND USES THEREOF | Fred Hutchinson Cancer Center (US) | 2023-02-08 | — | — | EP | claimed |
| CN-115397515-A | Human anti-CD 33 antibodies and uses thereof | 弗莱德哈钦森癌症中心 | 2022-11-25 | — | — | CN | claimed |
| CN-115297932-A | anti-CD 33 antibodies and uses thereof | 弗莱德哈钦森癌症中心 | 2022-11-04 | — | — | CN | claimed |
| CN-110227170-B | Radioactive microsphere and preparation method thereof | 白金科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| US-12600801-B2 | Single-domain antibodies that bind ROR1 | FRED HUTCHINSON CANCER CENTER (US) | 2026-04-14 | — | — | US | disclosed |
| US-20260085064-A1 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | KARYOPHARM THERAPEUTICS INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260084978-A1 | PROCESS FOR PRODUCING ATOMIC QUANTUM CLUSTERS DERIVATIVES | NANOGAP SUB NM POWDER S A (ES) | 2026-03-26 | — | — | US | disclosed |
| EP-4709424-A1 | LYOPHILIZED PRODUCTS, PHARMACEUTICAL COMPOSITIONS, AND KITS COMPRISING DYE-PEPTIDE CONJUGATES AND DERIVATIVES | Integro Theranostics, LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| CN-108440515-B | Substituted benzofuranyl and benzoxazolyl compounds and uses thereof | 卡尔约药物治疗公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114340690-A | Ocular device delivery methods and systems | 雷尔生物公司 | 2022-04-12 | — | — | CN | disclosed |
| EP-3962498-A1 | COMBINATION THERAPIES | Memorial Sloan Kettering Cancer Center (US) | 2022-03-09 | — | — | EP | disclosed |
| US-20220054550-A1 | COMBINATION THERAPIES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-02-24 | — | — | US | disclosed |
| CN-114025775-A | Combination therapy | 纪念斯隆-凯特琳癌症中心 | 2022-02-08 | — | — | CN | disclosed |